Chemistry and Physics Faculty Articles

Document Type

Article

Publication Date

11-5-2018

Publication Title

Biomedical Journal of Scientific & Technical Research

ISSN

2574-1241

Volume

10

Issue/No.

5

First Page

8054

Last Page

8058

Abstract

Human Immunodeficiency Virus (HIV) continues to be a major global public health issue. Inhibition of HIV envelope fusion with the CD4 cell membrane prevents the entry of HIV into the CD4 cells providing a novel approach to the treatment of HIV infection. Thus, interference in the fusion of the virus with the co-receptor substrate appears to be a specific and potential way to fight HIV infection and replication. Applications of click chemistry are spreading in the field of drug discovery and it became a powerful tool for the synthesis of medicinally important compounds.

Remarkably, the Cu (I)-Catalyzed Azide-Alkyne Cycloaddition (CuAAC) click chemistry has become a superior approach for the synthesis of privileged medicinal skeletons in the discovery of anti-HIV agents. Click reactions got enormous popularity because of a high degree of reliability, complete specificity (chemoselectivity and regioselectivity) and it employs chemical reactions that are wide in scope, of high yielding and produce very little or no by-products. In this review, we outlined current approaches towards the development of peptide based HIV fusion inhibitors employing click chemistry.

Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ORCID ID

0000-0002-7622-3986

ResearcherID

CFW-8633-2022

DOI

10.26717/BJSTR.2018.10.002004

Peer Reviewed

Included in

Chemistry Commons

COinS